ArticleCancer medicine2026

Synergistic Antitumor Activity of HAT Inhibitor A485 and XPO1 Inhibitor KPT8602 in Multiple Myeloma.

Hong Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.